NCT00236964View on ClinicalTrials.gov

Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on Dialysis

PHASE3CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

February 23, 2001

Primary Completion Date

May 30, 2002

Study Completion Date

May 30, 2002

Conditions
Anemia
Interventions
DRUG

Iron Sucrose + Erythropoietin

The total dose of iron sucrose was 1,000 mg. Participants also received erythropoietin 2,000 units subcutaneously on Days 1, 8, 15, 22, 29, and 36.

DRUG

Oral Iron + Erythropoietin

Oral iron 325 mg three time daily for 29 days. Participants also received erythropoietin 2,000 units subcutaneously on Days 1, 8, 15, 22, 29, and 36.

Sponsors
All Listed Sponsors
lead

American Regent, Inc.

INDUSTRY